OMRT-12. Nanoparticle-based CRISPR-Cas9 delivery for anti-glioblastoma immunotherapy
OMRT-12. 基于纳米颗粒的 CRISPR-Cas9 递送系统用于抗胶质母细胞瘤免疫治疗
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.80.18.5550
Thomae, R; Beck, S; Pohl, F M; Singh, Mahipal; Aguilar, Rocio; Fierro, Javier; Perez, Joshua; Dou, Huanyu